PO.MCB09.02 · 分子与细胞生物学
Metabolic Vulnerabilities in Pancreatic, Hepatic, and Renal Cancers
- 7315 7315 Polysulfides contribute to persulfidation of FSCN-1 to accelerate development of pancreatic ductal adenocarcinoma Makoto Suematsu, Takehiro Yamamoto, Minako Takizawa, Chiyoko Nishime, Masami Suzuki, Nobuyoshi Hiraoka
-
- 7317 7317 Dual targeting of SLC6A14 and autophagy/macropinocytosis enhances therapeutic efficacy in pancreatic ductal adenocarcinoma Mosharaf Mahmud Syed, Devaraja Rajasekaran, Souad R. Sennoune, Tanima Sharker, Oscar Sanchez, Mary Katherine Jurek, Longfa Kou, Ruijie Chen, Vadivel Ganapathy, Yangzom D. Bhutia
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- 7332 7332 Targeting a DYRK1A-regulated lipogenesis-STING axis alleviates hepatic metabolic dysfunction and lipotoxicity in metabolic steatohepatitis Wen Yan Huang, Kyunghee Noh
-
-
-
- 7336 7336 Harnessing lipid metabolism to treat drug-tolerant persister cells Mumina Sadullozoda, Patrick Jonker, Erin Szuromi, Asha Bozicevich, Alexander Muir
-
- 7338 7338 Elucidating the interplay between phospholipid biosynthesis and oxidative stress responses in the tumorigenesis of Clear Cell Renal Cell Carcinoma Rento Ito, Renpei Kato, Yosuke Matsushita, Toyomasa Katagiri, Wataru Obara
- 7339 7339 Transcriptomic features associated with tumoral metabolites characterizing the immune microenvironment in clear cell renal cell carcinoma Sei Naito, Takafumi Narisawa, Hiromi Ito, Norihiko Tschiya
-
